Your browser doesn't support javascript.
loading
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor.
Yukihiro, Kazuma; Teishima, Jun; Goto, Keisuke; Aoki, Gaku; Sekino, Yohei; Hayashi, Tetsutaro; Hasegawa, Yasuhisa; Mita, Koji; Kato, Masao; Kajiwara, Mitsuru; Shigeta, Masanobu; Maruyama, Satoshi; Kadonishi, Yuichi; Fujiwara, Seiji; Hinata, Nobuyuki.
Afiliação
  • Yukihiro K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Department of Urology, Fukuyama Medical Center, Fukuyama, Japan.
  • Teishima J; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: teishima@hiroshima-u.ac.jp.
  • Goto K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Aoki G; Clinical Research Center, Hiroshima University Hospital, Hiroshima, Japan.
  • Sekino Y; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Hayashi T; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Hasegawa Y; Department of Urology, Fukuyama Medical Center, Fukuyama, Japan.
  • Mita K; Department of Urology, Hiroshima-City Asa Citizens Hospital, Hiroshima, Japan.
  • Kato M; Department of Urology, Hiroshima General Hospital, Hatsukaichi, Japan.
  • Kajiwara M; Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Shigeta M; Department of Urology, Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Maruyama S; Department of Urology, Miyoshi Central Hospital, Miyoshi, Japan.
  • Kadonishi Y; Department of Urology, Onomichi General Hospital, Onomichi, Japan.
  • Fujiwara S; Department of Urology, Higashi-Hiroshima Medical Center, Higashi-Hiroshima, Japan.
  • Hinata N; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Urol Oncol ; 40(10): 455.e11-455.e18, 2022 10.
Article em En | MEDLINE | ID: mdl-35851184
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article